ELEWSKI, B.; MENTER, A.; CROWLEY, J.; TYRING, S.; ZHAO, Y.; LOWRY, S.; ROZZO, S.; MENDELSOHN, A.; PARNO, J.; GORDON, K. Sustained and Improved Efficacy of Tildrakizumab from Week 28 to Week 52 in Treating Moderate-to-Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S22, 2018. DOI: 10.25251/skin.2.supp.22. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/305. Acesso em: 23 jul. 2024.